Compass Therapeutics, Inc. (CMPX) has a market capitalization of $752.28M and trades at $5.44. The 52-week range is 1.4-6.88.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13, Earnings Per Share (EPS) of $-0.42.
The stock has a beta of 1.30, operates in the Healthcare sector.
